Merck to Present New Data Reinforcing Long-Term Efficacy of GARDASIL®9 and GARDASIL® at the EUROGIN International Multidisciplinary HPV Congress 2026

Go back to Merck to Present New Data Reinforcing Long-Term Efficacy of GARDASIL®9 and GARDASIL® at the EUROGIN International Multidisciplinary HPV Congress 2026
Merck & Co. (NYSE: MRK) Delayed: 115.48 --0 (-0%)
Previous Close $115.48    52 Week High $65.46 
Open $115.48    52 Week Low $47.97 
Day High $115.48    P/E 78.56 
Day Low $115.48    EPS $1.47 
Volume 13,263